Sanofi (SNYNF) Work In Process (2015 - 2018)
Sanofi (SNYNF) posted Work In Process of $4.7 billion for Q4 2018, up 7.34% sequentially from $4.3 billion in Q4 2017, and up 7.34% YoY from $4.3 billion in Q4 2017.
Sanofi (SNYNF) Work In Process (2015 - 2018) Analysis & Trends
Sanofi (SNYNF) has 4 years of Work In Process data on file, last reported at $4.7 billion in Q4 2018.
- Quarterly Work In Process rose 7.34% year-over-year to $4.7 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $4.7 billion (up 7.34% YoY) and the FY2018 annual result came in at $4.7 billion, up 11.91% from the prior year.
- Work In Process improved to $4.7 billion in Q4 2018 per SNYNF's latest filing, from $4.3 billion in the prior quarter.
- The five-year high for Work In Process was $4.7 billion in Q4 2018, with the low at $3.8 billion in Q4 2015.
- Average Work In Process over 4 years is $4.2 billion, with a median of $4.2 billion recorded in 2016.
- Year-over-year, Work In Process increased 7.56% in 2016 and grew 5.89% in 2017.
- Sanofi's Work In Process stood at $3.8 billion in 2015, then increased by 7.56% to $4.1 billion in 2016, then advanced by 5.89% to $4.3 billion in 2017, then advanced by 7.34% to $4.7 billion in 2018.
- Business Quant data shows SNYNF's Work In Process at $4.7 billion in Q4 2018, $4.3 billion in Q4 2017, and $4.1 billion in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Sanofi | - | - | 9.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 4.67 Bn |
| Dec 31, 2017 | 4.35 Bn |
| Dec 31, 2016 | 4.11 Bn |
| Dec 31, 2015 | 3.82 Bn |